Keith Manchester - Sep 12, 2023 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)

Role
Director
Signature
By: /s/ Jo Chen, as Attorney-in-Fact for Keith Manchester
Stock symbol
ROIV
Transactions as of
Sep 12, 2023
Transactions value $
$0
Form type
4
Date filed
9/14/2023, 09:30 PM
Previous filing
May 26, 2023
Next filing
Oct 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ROIV Common Shares Award $0 +17.8K +34.19% $0.00 70K Sep 12, 2023 Direct F1
holding ROIV Common Shares 37.5M Sep 12, 2023 Held by QVT Financial Investment Cayman Ltd. F2
holding ROIV Common Shares 13.5M Sep 12, 2023 Held by QVT Roiv Hldgs Onshore Ltd. F2
holding ROIV Common Shares 28M Sep 12, 2023 Held by QVT Deferred Compensation Holdings Ltd. F2
holding ROIV Common Shares 5.47M Sep 12, 2023 Held by QVT P&E Roiv Hldgs Ltd. F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ROIV Stock Option (Right to Buy) Award $0 +26.6K $0.00 26.6K Sep 12, 2023 Common Shares 26.6K $11.22 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects an annual award of restricted stock units with respect to Common Shares ("RSUs") granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of RSUs is scheduled to vest 100% on September 12, 2024, subject generally to the reporting person's continuous service through such date.
F2 The reporting person is a shareholder of each of QVT Roiv Hldgs Onshore Ltd., QVT Deferred Compensation Holdings Ltd., QVT P&E Roiv Hldgs Ltd. and QVT Financial Investment Cayman Ltd. (the "QVT Entities") but does not have any voting or investment control over the QVT Entities. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.
F3 Reflects an annual award of stock options to purchase Common Shares granted pursuant to the Company's 2021 Equity Incentive Plan and the Company's Non-Employee Director Compensation Policy. The award of stock options is scheduled to vest and become exercisable 100% on September 12, 2024, subject generally to the reporting person's continuous service through such date.